Clinical Trial Update: Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mesenchymal stem cell therapy for radiation-induced xerostomia in head and neck cancer survivors; safety and efficacy outcomes are bein…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xerostomia Following Radiotherapy

Drugs mentioned

• Mesenchymal Stem Cell (mesenchymal stem cell)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Xerostomia Following Radiotherapy | Phase 2 | Status: UNKNOWN